Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Strategy
Strategic Acquisitions: Their Mistake Could Be Your Next Opportunity
During this interest rate and inflation cycle, make your M&A shopping list early but be selective.
By
Kal Vadasz
| June 27, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Salix Pharmaceuticals
Risk & Compliance
Allergan Fined $15M Over Disclosure Failures
The SEC says the drug maker failed to timely inform investors about its merger talks with Salix and Actavis.
By
Matthew Heller
| January 18, 2017
Read More
Supply Chain
Salix CFO Resigns as Board Reviews Inventory Accounting
Are high levels of inventory at wholesalers indicative of improper accounting of sales?
By
Matthew Heller
| November 10, 2014
Read More
Tax
Salix Calls Off Tax Inversion Deal
The Treasury Department's recent anti-inversion measures claim their first victim — Salix Pharmaceuticals' plan to merge with Italy-based Cosmo.
By
Iris Dorbian
| October 3, 2014
Read More
Tax
Another Tax Inversion Deal in the Works
The hue and cry over tax inversions is not stopping companies from proceeding with more mergers that take advantage of the tactic.
By
Iris Dorbian
| July 28, 2014
Read More